VolitionRX Ltd (NYSE American:VNRX)
| 1.66 Delayed Data As of Mar 24 |  +0.04 / +2.47%Today’s Change | 1.31 Today|||52-Week Range 3.30 | -31.69% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Innes Guy Archibald Director |  Buy | 8/02/2022 | 75,000 | $2.00 | $150.0K | -14.95% |
Innes Guy Archibald Director | Buy | 8/02/2022 | 75,000 | $2.00 | $150.0K | -14.95% |
Innes Guy Archibald Director | Buy | 8/02/2022 | 75,000 | $2.00 | $150.0K | -14.95% |
Innes Guy Archibald Director | Buy | 8/02/2022 | 75,000 | $2.00 | $150.0K | -14.95% |
Faulkes Martin C Director | Buy | 12/16/2022 | 55,000 | $2.10 | $115.5K | -22.54% |
Innes Guy Archibald Director | Buy | 2/22/2023 | 58,500 | $1.75 | $102.4K | -7.30% |
Innes Guy Archibald Director | Buy | 2/22/2023 | 58,500 | $1.75 | $102.4K | -7.30% |
Innes Guy Archibald Director | Buy | 2/22/2023 | 58,500 | $1.75 | $102.4K | -7.30% |
Innes Guy Archibald Director | Buy | 2/22/2023 | 58,500 | $1.75 | $102.4K | -7.30% |
Micallef Jacob Vincent Chief Scientific Officer | Buy | 12/19/2022 | 25,000 | $2.30 | $57.5K | -27.31% |
Page of 11